期刊文献+

氨甲环酸与Wnt信号通路中含kringle结构域蛋白的结合对新生小鼠骨密度的影响(英文)

The Effect of AMCA Binding to Kringle Containing Proteins of Wnt Signaling Pathway on Bone Mineral Densities of New Born Mice
下载PDF
导出
摘要 最近研究发现Wnt信号通路在骨形成过程中发挥重要作用.Wnt受体如脂蛋白相关蛋白5(lrp5)和孤独受体(Ror2)的缺失或突变导致骨的不正常发育.Dkk是一个分泌型规范Wnt信号系统的抑制剂,通过与脂蛋白相关蛋白5和最近新发现的一种含kringle结构域的蛋白kremen形成三聚体复合物.这种复合物随即被细胞内吞,从而导致细胞表面Wnt受体脂蛋白相关蛋白5水平迅速下降,从而达到抑制Wnt信号通路的目地.通过对kremen和Ror2蛋白序列分析发现kremen和Ror2的胞外部分均含有一个结构上能与赖氨酸结合的kringle结构域.通过给怀孕母鼠注射一种赖氨酸类似物———氨甲环酸来研究kremen和Ror2的kringle结构域上的赖氨酸结合位点被占据对小鼠骨发育的作用.但是,研究结果表明AMCA组和对照组之间的骨密度并没有显著差异,揭示赖氨酸结合位点不参与骨的发育调控. It is recently found that Wnt signaling pathway plays a crucial role in bone formation. Mutation or deletion of Wnt co-receptor lipoprotein related protein 5 (LRP5) or an orphan receptor tyrosine kinase Ror2 results in abnormal bone development. Dickkopf (Dkk), a secreted canonical Wnt/catenin signaling inhibitor, is able to form a ternary complex with LRP5/6 and a newly discovered protein, kremen. It mediates endocytosis of LRP5/6, thus inhibits Wnt signaling pathway by removal of cell surface receptors. Based on the structural analysis using protein sequences of kremen and Ror2, we found that each of them has an extracellular kringle domain which is structurally capable for lysine binding. In this study we injected AMCA, a lysine analog, to pregnant mice to see its effect on bone development of new born mice through occupancy of lysine binding sites of kringle domains of Ror2 and kremen. The results showed no significant difference of bone mineral density (BMD) in AMCA treated groups compared with the control group, suggesting that lysine binding sites of kringles are not involved in the process of bone formation.
出处 《南京大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第5期470-477,共8页 Journal of Nanjing University(Natural Science)
关键词 WNT 脂蛋白相关蛋白5 孤独受体2 Dkk kremen 骨密度 KRINGLE Wnt, LRP5, Ror2, Dkk, kremen, BMD, kringle
  • 相关文献

参考文献6

二级参考文献32

  • 1刘建宁 陈于红.抑制血管内皮细胞及内皮干细胞生长及迁移的多肽及其制备方法和用途[P].中国专利申请号011081791.2001.
  • 2Folkman J. Angiogenesis in cancer, vascular, rheumaroid and other disease. Nature Medicine, 1995, 1(1) :27--31.
  • 3Hayes A J, Li L Y, Lippman M E. Science, medicine, and the future. Antivascular therapy: A new approach to cancer treatment. British Medical Journal, 1999, 318(7 187):853-856.
  • 4Rowe P M. Starve the tumor, save the patient. Lancet, 1997,349 (9 095):1 058.
  • 5O'Reilly M S, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 1994,79(2): 315--328.
  • 6Gately S, Twardowski P, Stack M S, et al. Human prostate carcinoma cells express enzymatic activity that covers human plasminogen to the angiogenesis inhibitor angiostatin. Cancer Research, 1996,56(21):4 887--4 890.
  • 7Gately S, Twardowski P, Stack M S, et al. The mechanism of cancer medicated conversion of plamainogen to the angiogenesis inhibitor angiostatin. Proceedings of National Academy of Sciences of the United States of America, 1997, 94(20): 10 868--10 872.
  • 8Dong Z, Kurnar R, Yang X, et al. Marcrophage derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 1997, 88(6): 801--810.
  • 9Cao R H, Wu H L, Veitonmaki N, et al. Suppression of angiogenesis and tumor growth by the inhibitor K1- 5 generated by plasmin-mediated proteolysis. Proceedings of National Academy of Sciences of the United States of America, 1999, 96(10): 5 728--5 733.
  • 10Tomioka D, Maehara N. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Research, 2001, 61(20) : 7 518--7 524.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部